Thiazide-like Diuretic [EPC]

Thiazide-like Diuretic [EPC] was reported 43140 times

These side effects are most commonly reported by patients taking drugs of the Thiazide-like Diuretic [EPC] class:

# Drug class Count
0 DYSPNOEA 2839
1 NAUSEA 2576
2 FATIGUE 2541
3 DIARRHOEA 2398
4 DIZZINESS 2283
5 ACUTE KIDNEY INJURY 2271
6 DRUG INEFFECTIVE 1968
7 HEADACHE 1962
8 HYPONATRAEMIA 1910
9 ASTHENIA 1773
10 PAIN 1674
11 FALL 1633
12 OFF LABEL USE 1617
13 VOMITING 1576
14 HYPOTENSION 1544
15 MALAISE 1528
16 ARTHRALGIA 1446
17 DEATH 1416
18 COUGH 1370
19 HYPOKALAEMIA 1362
20 RENAL FAILURE 1337
21 HYPERTENSION 1258
22 PNEUMONIA 1257
23 DRUG INTERACTION 1232
24 CHRONIC KIDNEY DISEASE 1179
25 OEDEMA PERIPHERAL 1173
26 WEIGHT DECREASED 1171
27 RASH 1139
28 PAIN IN EXTREMITY 1116
29 CONDITION AGGRAVATED 1050
30 BLOOD PRESSURE INCREASED 1045
31 PERIPHERAL SWELLING 1014
32 PRURITUS 983
33 DEHYDRATION 971
34 ANAEMIA 943
35 CONFUSIONAL STATE 943
36 DECREASED APPETITE 927
37 PYREXIA 918
38 ATRIAL FIBRILLATION 908
39 CHEST PAIN 890
40 BACK PAIN 880
41 WEIGHT INCREASED 876
42 CONSTIPATION 872
43 CARDIAC FAILURE CONGESTIVE 870
44 ABDOMINAL PAIN 835
45 URINARY TRACT INFECTION 759
46 GAIT DISTURBANCE 758
47 INSOMNIA 755
48 ANXIETY 747
49 SYNCOPE 747
50 MYALGIA 738
51 BLOOD CREATININE INCREASED 685
52 MUSCLE SPASMS 683
53 CARDIAC FAILURE 681
54 RENAL IMPAIRMENT 678
55 FEELING ABNORMAL 673
56 ABDOMINAL PAIN UPPER 664
57 SOMNOLENCE 649
58 BLOOD GLUCOSE INCREASED 629
59 FLUID RETENTION 615
60 JOINT SWELLING 615
61 HAEMOGLOBIN DECREASED 595
62 NASOPHARYNGITIS 554
63 GASTROINTESTINAL HAEMORRHAGE 553
64 ABDOMINAL DISCOMFORT 530
65 MUSCULAR WEAKNESS 527
66 PRODUCT DOSE OMISSION ISSUE 527
67 DEPRESSION 525
68 LOSS OF CONSCIOUSNESS 520
69 RENAL FAILURE ACUTE 506
70 CHEST DISCOMFORT 497
71 BRADYCARDIA 496
72 HYPERKALAEMIA 490
73 OEDEMA 486
74 COVID-19 482
75 TREMOR 481
76 BLOOD POTASSIUM DECREASED 477
77 INFLUENZA 474
78 CEREBROVASCULAR ACCIDENT 472
79 DRUG HYPERSENSITIVITY 472
80 MYOCARDIAL INFARCTION 468
81 HYPERSENSITIVITY 453
82 END STAGE RENAL DISEASE 452
83 PALPITATIONS 448
84 HYPERHIDROSIS 441
85 ERYTHEMA 440
86 ASTHMA 438
87 PARAESTHESIA 437
88 OROPHARYNGEAL PAIN 428
89 BLOOD PRESSURE DECREASED 421
90 HYPOAESTHESIA 417
91 SEPSIS 417
92 DIABETES MELLITUS 415
93 VISION BLURRED 414
94 WHEEZING 413
95 EPISTAXIS 406
96 PRODUCT USE IN UNAPPROVED INDICATION 406
97 DYSPNOEA EXERTIONAL 402
98 CONTUSION 399
99 TOXICITY TO VARIOUS AGENTS 395
100 ABDOMINAL DISTENSION 391
101 GENERAL PHYSICAL HEALTH DETERIORATION 371
102 CARDIAC ARREST 368
103 PRODUCT USE ISSUE 362
104 HOSPITALISATION 361
105 SWELLING 359
106 DRUG INTOLERANCE 358
107 GASTROOESOPHAGEAL REFLUX DISEASE 358
108 ALOPECIA 355
109 CELLULITIS 346
110 OXYGEN SATURATION DECREASED 344
111 URTICARIA 342
112 VISUAL IMPAIRMENT 342
113 INJECTION SITE PAIN 337
114 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 336
115 ARTHRITIS 330
116 HEART RATE INCREASED 330
117 PRODUCTIVE COUGH 329
118 SINUSITIS 328
119 CHILLS 327
120 MEMORY IMPAIRMENT 327
121 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 326
122 RESPIRATORY FAILURE 325
123 FLUSHING 322
124 RHABDOMYOLYSIS 322
125 THROMBOCYTOPENIA 318
126 CARDIAC DISORDER 317
127 INCORRECT DOSE ADMINISTERED 317
128 NEUROPATHY PERIPHERAL 312
129 PLEURAL EFFUSION 312
130 DYSPHAGIA 310
131 INFECTION 309
132 SWELLING FACE 306
133 DRY MOUTH 304
134 HYPOMAGNESAEMIA 302
135 PULMONARY EMBOLISM 301
136 DYSPEPSIA 300
137 INTENTIONAL PRODUCT USE ISSUE 300
138 ILLNESS 298
139 LETHARGY 296
140 BALANCE DISORDER 295
141 MOBILITY DECREASED 295
142 PULMONARY OEDEMA 291
143 HAEMORRHAGE 286
144 NASAL CONGESTION 285
145 ARRHYTHMIA 284
146 BRONCHITIS 283
147 LACTIC ACIDOSIS 277
148 BLOOD SODIUM DECREASED 271
149 HYPOGLYCAEMIA 270
150 RENAL INJURY 269
151 GASTROINTESTINAL DISORDER 264
152 HEART RATE DECREASED 264
153 MUSCULOSKELETAL STIFFNESS 264
154 PRESYNCOPE 263
155 PULMONARY HYPERTENSION 262
156 RENAL DISORDER 260
157 SEIZURE 256
158 GOUT 255
159 NEUTROPENIA 254
160 TACHYCARDIA 254
161 ELECTROCARDIOGRAM QT PROLONGED 253
162 NEPHROGENIC ANAEMIA 253
163 ANGIOEDEMA 249
164 HOT FLUSH 249
165 BLOOD UREA INCREASED 245
166 ALANINE AMINOTRANSFERASE INCREASED 242
167 FLUID OVERLOAD 242
168 OSTEOARTHRITIS 242
169 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 241
170 STRESS 239
171 TREATMENT NONCOMPLIANCE 239
172 HYPOXIA 237
173 NECK PAIN 236
174 PLATELET COUNT DECREASED 235
175 BLOOD PRESSURE SYSTOLIC INCREASED 234
176 DISEASE PROGRESSION 233
177 OVERDOSE 225
178 WHITE BLOOD CELL COUNT DECREASED 225
179 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 222
180 DRUG DOSE OMISSION 220
181 RHINORRHOEA 218
182 CATARACT 217
183 HAEMATOCHEZIA 215
184 PULMONARY ARTERIAL HYPERTENSION 215
185 METABOLIC ACIDOSIS 214
186 RECTAL HAEMORRHAGE 213
187 SKIN EXFOLIATION 213
188 DYSPHONIA 212
189 ORTHOSTATIC HYPOTENSION 211
190 PSORIASIS 209
191 BLISTER 207
192 DRY SKIN 207
193 BLOOD PRESSURE FLUCTUATION 204
194 DEEP VEIN THROMBOSIS 204
195 DYSURIA 204
196 RHEUMATOID ARTHRITIS 204
197 ASPARTATE AMINOTRANSFERASE INCREASED 203
198 BONE PAIN 203
199 MUSCULOSKELETAL PAIN 203
200 THROMBOSIS 202
201 SLEEP DISORDER 201
202 UPPER RESPIRATORY TRACT INFECTION 201
203 VERTIGO 201
204 LUNG DISORDER 200
205 POLLAKIURIA 199
206 DEPRESSED MOOD 197
207 WHITE BLOOD CELL COUNT INCREASED 196
208 HALLUCINATION 195
209 MEDICATION ERROR 195
210 TUBULOINTERSTITIAL NEPHRITIS 195
211 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 194
212 C-REACTIVE PROTEIN INCREASED 192
213 GLOMERULAR FILTRATION RATE DECREASED 192
214 BLOOD POTASSIUM INCREASED 191
215 HYPERGLYCAEMIA 191
216 DISORIENTATION 190
217 FLATULENCE 190
218 BURNING SENSATION 189
219 INTERNATIONAL NORMALISED RATIO INCREASED 187
220 UNEVALUABLE EVENT 187
221 BLOOD GLUCOSE DECREASED 186
222 LOWER RESPIRATORY TRACT INFECTION 186
223 CORONARY ARTERY DISEASE 185
224 INFLUENZA LIKE ILLNESS 185
225 THROAT IRRITATION 185
226 DYSGEUSIA 184
227 SEPTIC SHOCK 184
228 FEELING HOT 180
229 ACUTE RESPIRATORY FAILURE 178
230 HEPATIC ENZYME INCREASED 177
231 TYPE 2 DIABETES MELLITUS 175
232 NEPHROLITHIASIS 174
233 ACUTE MYOCARDIAL INFARCTION 171
234 EMOTIONAL DISTRESS 171
235 HAEMATURIA 171
236 EYE PAIN 170
237 MIGRAINE 170
238 ARTHROPATHY 168
239 SLEEP APNOEA SYNDROME 168
240 AMNESIA 167
241 URINARY INCONTINENCE 167
242 ASCITES 166
243 AGITATION 163
244 HAEMATOMA 162
245 PAIN IN JAW 162
246 RIGHT VENTRICULAR FAILURE 162
247 VENTRICULAR TACHYCARDIA 162
248 STOMATITIS 161
249 ELECTROLYTE IMBALANCE 160
250 HEPATIC STEATOSIS 160
251 HYPOCALCAEMIA 160
252 RASH PRURITIC 160
253 PRODUCT QUALITY ISSUE 158
254 BLOOD PRESSURE ABNORMAL 157
255 CHOLELITHIASIS 157
256 OBESITY 157
257 PRODUCT DOSE OMISSION 157
258 ANGINA PECTORIS 156
259 THERAPY INTERRUPTED 156
260 BLOOD CHOLESTEROL INCREASED 154
261 SKIN DISCOLOURATION 154
262 URINARY RETENTION 154
263 DISEASE RECURRENCE 152
264 HEART RATE IRREGULAR 152
265 RESPIRATORY DISTRESS 152
266 INJURY 151
267 INTENTIONAL PRODUCT MISUSE 151
268 MALIGNANT NEOPLASM PROGRESSION 151
269 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 151
270 TINNITUS 151
271 DELIRIUM 150
272 DYSARTHRIA 150
273 LIP SWELLING 149
274 CARDIO-RESPIRATORY ARREST 147
275 SWOLLEN TONGUE 146
276 HEAD INJURY 145
277 INFUSION RELATED REACTION 145
278 NEPHROPATHY 145
279 HERPES ZOSTER 141
280 RASH ERYTHEMATOUS 141
281 ERECTILE DYSFUNCTION 138
282 PERICARDIAL EFFUSION 138
283 UNDERDOSE 138
284 INFUSION SITE PAIN 137
285 LOCALISED INFECTION 137
286 HYPOPHAGIA 136
287 COMPLETED SUICIDE 135
288 GASTRITIS 135
289 HYPOTHYROIDISM 135
290 HYPOVOLAEMIA 134
291 TRANSIENT ISCHAEMIC ATTACK 132
292 CONTRAINDICATED PRODUCT ADMINISTERED 131
293 ILL-DEFINED DISORDER 131
294 PANCREATITIS 131
295 SKIN ULCER 131
296 SPEECH DISORDER 130
297 FEELING COLD 129
298 HYPERPARATHYROIDISM SECONDARY 129
299 ADVERSE DRUG REACTION 128
300 ECONOMIC PROBLEM 128
301 GLYCOSYLATED HAEMOGLOBIN INCREASED 128
302 HAEMATOCRIT DECREASED 128
303 LIMB INJURY 127
304 ANAPHYLACTIC REACTION 126
305 LIMB DISCOMFORT 126
306 TORSADE DE POINTES 126
307 HYPERVOLAEMIA 125
308 UPPER GASTROINTESTINAL HAEMORRHAGE 125
309 INJECTION SITE BRUISING 124
310 PANCYTOPENIA 124
311 POLYURIA 124
312 LIVER DISORDER 123
313 MELAENA 123
314 SYSTEMIC LUPUS ERYTHEMATOSUS 123
315 CARDIAC MURMUR 122
316 DRY EYE 122
317 EOSINOPHILIA 122
318 RASH MACULO-PAPULAR 122
319 DISCOMFORT 121
320 GENERALISED OEDEMA 121
321 INTERSTITIAL LUNG DISEASE 121
322 OSTEOPOROSIS 121
323 WOUND 121
324 INJECTION SITE ERYTHEMA 120
325 MENTAL STATUS CHANGES 120
326 SKIN LESION 120
327 BLOOD URINE PRESENT 119
328 MITRAL VALVE INCOMPETENCE 119
329 COVID-19 PNEUMONIA 118
330 RED BLOOD CELL COUNT DECREASED 118
331 DIVERTICULITIS 117
332 JAUNDICE 117
333 LEUKOCYTOSIS 117
334 SEASONAL ALLERGY 117
335 THERAPY CESSATION 117
336 ARTERIOSCLEROSIS 116
337 BLOOD CREATINE PHOSPHOKINASE INCREASED 116
338 EJECTION FRACTION DECREASED 116
339 SHOCK 116
340 DEPRESSED LEVEL OF CONSCIOUSNESS 114
341 INFLAMMATION 114
342 MOUTH ULCERATION 114
343 MULTIPLE ORGAN DYSFUNCTION SYNDROME 114
344 PANCREATITIS ACUTE 114
345 SURGERY 114
346 STEVENS-JOHNSON SYNDROME 113
347 INTESTINAL OBSTRUCTION 112
348 ANHEDONIA 111
349 DISTURBANCE IN ATTENTION 111
350 PROTEIN URINE PRESENT 111
351 RESPIRATORY TRACT INFECTION 110
352 CARDIOMEGALY 109
353 CEREBRAL HAEMORRHAGE 109
354 DIABETES MELLITUS INADEQUATE CONTROL 109
355 HYPERLIPIDAEMIA 109
356 STAPHYLOCOCCAL INFECTION 109
357 RESPIRATORY DISORDER 108
358 HAEMORRHOIDS 107
359 CYSTITIS 106
360 LIVER FUNCTION TEST ABNORMAL 106
361 SPINAL OSTEOARTHRITIS 106
362 THERAPEUTIC PRODUCT EFFECT DECREASED 106
363 THERAPY NON-RESPONDER 106
364 COLITIS 105
365 GASTRIC ULCER 105
366 IMPAIRED HEALING 105
367 PALLOR 105
368 URINE OUTPUT DECREASED 105
369 RESTLESSNESS 104
370 ROAD TRAFFIC ACCIDENT 104
371 TRICUSPID VALVE INCOMPETENCE 104
372 CARDIAC FAILURE ACUTE 103
373 NERVOUSNESS 103
374 COGNITIVE DISORDER 102
375 COMA 102
376 EYE IRRITATION 102
377 NIGHT SWEATS 102
378 PRODUCT SUBSTITUTION ISSUE 102
379 THERAPEUTIC RESPONSE DECREASED 102
380 ECZEMA 101
381 HAEMOPTYSIS 100
382 HYPERSOMNIA 100
383 PROTEINURIA 100
384 PSYCHOTIC DISORDER 100
385 CARDIOMYOPATHY 99
386 DEVICE ISSUE 99
387 HYPOACUSIS 99
388 ORAL PAIN 99
389 SINUS BRADYCARDIA 99
390 ADVERSE EVENT 98
391 ATELECTASIS 98
392 LABORATORY TEST ABNORMAL 98
393 RENAL FAILURE CHRONIC 98
394 VASCULITIS 98
395 BLOOD BILIRUBIN INCREASED 97
396 DEVICE MALFUNCTION 97
397 HAEMATEMESIS 97
398 HYPERTENSIVE CRISIS 97
399 SKIN DISORDER 97
400 SUICIDAL IDEATION 97
401 UNRESPONSIVE TO STIMULI 97
402 DYSLIPIDAEMIA 96
403 HALLUCINATION, VISUAL 96
404 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 96
405 DIZZINESS POSTURAL 95
406 MUSCULOSKELETAL DISCOMFORT 95
407 RED BLOOD CELL SEDIMENTATION RATE INCREASED 95
408 RIB FRACTURE 95
409 CIRCULATORY COLLAPSE 94
410 JOINT STIFFNESS 94
411 EATING DISORDER 92
412 FULL BLOOD COUNT DECREASED 92
413 INJECTION SITE HAEMORRHAGE 92
414 NIGHTMARE 92
415 CLOSTRIDIUM DIFFICILE INFECTION 91
416 COAGULOPATHY 91
417 HYPERTHYROIDISM 91
418 PERIPHERAL COLDNESS 91
419 REBOUND ACID HYPERSECRETION 91
420 RESTLESS LEGS SYNDROME 91
421 BREAST CANCER 90
422 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 90
423 VENTRICULAR EXTRASYSTOLES 90
424 BREATH SOUNDS ABNORMAL 89
425 CONVULSION 89
426 DRUG-INDUCED LIVER INJURY 89
427 INFUSION SITE ERYTHEMA 89
428 INJECTION SITE MASS 89
429 ORTHOPNOEA 89
430 RENAL TUBULAR NECROSIS 89
431 SINUS CONGESTION 89
432 CHOLESTASIS 88
433 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 88
434 FAECES DISCOLOURED 88
435 BLOOD MAGNESIUM DECREASED 87
436 FEBRILE NEUTROPENIA 87
437 IRON DEFICIENCY ANAEMIA 87
438 LUNG NEOPLASM MALIGNANT 87
439 THYROID DISORDER 87
440 ACUTE RESPIRATORY DISTRESS SYNDROME 86
441 GAIT INABILITY 86
442 INJECTION SITE PRURITUS 86
443 MASS 86
444 MENTAL DISORDER 86
445 NEEDLE ISSUE 86
446 NEOPLASM MALIGNANT 86
447 GALLBLADDER DISORDER 85
448 LEFT VENTRICULAR HYPERTROPHY 85
449 RALES 85
450 BLOOD ALKALINE PHOSPHATASE INCREASED 84
451 BLOOD TRIGLYCERIDES INCREASED 84
452 CARDIOGENIC SHOCK 84
453 EYE SWELLING 84
454 INTENTIONAL DOSE OMISSION 84
455 INTENTIONAL OVERDOSE 84
456 NEURALGIA 84
457 PSORIATIC ARTHROPATHY 84
458 BLOOD PRESSURE INADEQUATELY CONTROLLED 83
459 NO ADVERSE EVENT 83
460 NOCTURIA 83
461 ARTERIOSCLEROSIS CORONARY ARTERY 82
462 DYSKINESIA 82
463 HYPERCALCAEMIA 82
464 SINUS DISORDER 82
465 CROHN^S DISEASE 81
466 EAR INFECTION 81
467 MYOCARDIAL ISCHAEMIA 81
468 TRANSFUSION 81
469 HEPATIC CIRRHOSIS 80
470 PULMONARY CONGESTION 80
471 VIRAL INFECTION 80
472 APHASIA 79
473 CORONARY ARTERY OCCLUSION 79
474 POOR QUALITY SLEEP 79
475 CHROMATURIA 78
476 DRUG LEVEL INCREASED 78
477 DYSSTASIA 78
478 FEAR 78
479 GASTRIC DISORDER 78
480 ISCHAEMIC STROKE 78
481 OCULAR HYPERAEMIA 78
482 RASH MACULAR 78
483 MUCOSAL INFLAMMATION 77
484 THROAT TIGHTNESS 77
485 HYPOVOLAEMIC SHOCK 76
486 BONE DISORDER 75
487 HIP FRACTURE 75
488 JOINT INJURY 75
489 LUPUS NEPHRITIS 75
490 OSTEOPENIA 75
491 PRODUCT PRESCRIBING ERROR 75
492 PRURITUS GENERALISED 75
493 THIRST 75
494 BLOOD PRESSURE SYSTOLIC ABNORMAL 74
495 COLITIS ULCERATIVE 74
496 GASTROENTERITIS 74
497 TOXIC EPIDERMAL NECROLYSIS 74
498 ATRIOVENTRICULAR BLOCK 73
499 EXOSTOSIS 73
500 MULTI-ORGAN FAILURE 73
501 SPINAL FRACTURE 73
502 VISUAL ACUITY REDUCED 73
503 IRRITABILITY 72
504 LACRIMATION INCREASED 72
505 MOVEMENT DISORDER 72
506 RASH PAPULAR 72
507 RETCHING 72
508 SKIN BURNING SENSATION 72
509 THERAPEUTIC RESPONSE UNEXPECTED 72
510 HEPATITIS 71
511 HIATUS HERNIA 71
512 METABOLIC ALKALOSIS 71
513 MYOCLONUS 71
514 PNEUMONIA ASPIRATION 71
515 POLYP 71
516 SEDATION 71
517 SKIN LACERATION 71
518 SUICIDE ATTEMPT 71
519 TACHYARRHYTHMIA 71
520 URINE ODOUR ABNORMAL 71
521 ANURIA 70
522 FOOT FRACTURE 70
523 FUNGAL INFECTION 70
524 GAMMA-GLUTAMYLTRANSFERASE INCREASED 70
525 INTERVERTEBRAL DISC PROTRUSION 70
526 LYMPHADENOPATHY 70
527 OLIGURIA 70
528 OSTEOMYELITIS 70
529 RENAL ARTERY STENOSIS 70
530 UROSEPSIS 70
531 VENTRICULAR FIBRILLATION 70
532 WITHDRAWAL SYNDROME 70
533 DIALYSIS 69
534 FURUNCLE 69
535 MUSCULOSKELETAL CHEST PAIN 69
536 PULMONARY MASS 69
537 SEROTONIN SYNDROME 69
538 SPINAL PAIN 69
539 ACNE 68
540 BLADDER DISORDER 68
541 CENTRAL NERVOUS SYSTEM LUPUS 68
542 GINGIVAL BLEEDING 68
543 PULMONARY FIBROSIS 68
544 RASH GENERALISED 68
545 DIABETIC KETOACIDOSIS 67
546 DRUG EFFECT DECREASED 67
547 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 67
548 FEEDING DISORDER 67
549 HEAD DISCOMFORT 67
550 LEUKOPENIA 67
551 PROSTATE CANCER 67
552 BUNDLE BRANCH BLOCK RIGHT 66
553 BUTTERFLY RASH 66
554 KNEE ARTHROPLASTY 66
555 LIVER FUNCTION TEST INCREASED 66
556 TACHYPNOEA 66
557 URINE ABNORMALITY 66
558 AGEUSIA 65
559 BLOOD COUNT ABNORMAL 65
560 BODY TEMPERATURE DECREASED 65
561 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 65
562 ENCEPHALOPATHY 65
563 OBSTRUCTIVE AIRWAYS DISORDER 65
564 PNEUMONITIS 65
565 TENDONITIS 65
566 TOOTHACHE 65
567 ATRIAL FLUTTER 64
568 BLOOD PRESSURE DIASTOLIC DECREASED 64
569 DUODENAL ULCER 64
570 EAR PAIN 64
571 SPUTUM DISCOLOURED 64
572 COLD SWEAT 63
573 DIASTOLIC DYSFUNCTION 63
574 GLAUCOMA 63
575 INFUSION SITE SWELLING 63
576 LOWER GASTROINTESTINAL HAEMORRHAGE 63
577 NEOPLASM PROGRESSION 63
578 BLINDNESS 62
579 DEVICE DISLOCATION 62
580 EYE PRURITUS 62
581 PANIC ATTACK 62
582 POST PROCEDURAL COMPLICATION 62
583 POSTOPERATIVE WOUND INFECTION 62
584 RESPIRATORY TRACT CONGESTION 62
585 SCIATICA 62
586 ULCER 62
587 ACCIDENTAL EXPOSURE TO PRODUCT 61
588 HAEMOGLOBIN INCREASED 61
589 HYPERCHOLESTEROLAEMIA 61
590 KIDNEY INFECTION 61
591 AZOTAEMIA 60
592 DEAFNESS 60
593 DEVICE LEAKAGE 60
594 ERUCTATION 60
595 FEMUR FRACTURE 60
596 HYPOKINESIA 60
597 MUSCLE TIGHTNESS 60
598 PROCTALGIA 60
599 BASAL CELL CARCINOMA 59
600 BLOOD GLUCOSE ABNORMAL 59
601 BRAIN NATRIURETIC PEPTIDE INCREASED 59
602 DEMENTIA 59
603 DRUG ERUPTION 59
604 HAEMORRHAGIC ANAEMIA 59
605 HELICOBACTER INFECTION 59
606 INJECTION SITE DISCOMFORT 59
607 INJECTION SITE SWELLING 59
608 LOWER LIMB FRACTURE 59
609 POOR VENOUS ACCESS 59
610 TRANSAMINASES INCREASED 59
611 EYE DISORDER 58
612 GASTROENTERITIS VIRAL 58
613 HEPATOTOXICITY 58
614 HERNIA 58
615 IMPAIRED GASTRIC EMPTYING 58
616 SNEEZING 58
617 CHOLECYSTITIS 57
618 DERMATITIS CONTACT 57
619 HEPATIC FUNCTION ABNORMAL 57
620 MULTIPLE INJURIES 57
621 SPLENOMEGALY 57
622 TASTE DISORDER 57
623 TREATMENT FAILURE 57
624 BLOOD IRON DECREASED 56
625 CARPAL TUNNEL SYNDROME 56
626 HYPOTONIA 56
627 INTERNAL HAEMORRHAGE 56
628 MULTIPLE SCLEROSIS RELAPSE 56
629 OESOPHAGITIS 56
630 PROSTATIC SPECIFIC ANTIGEN INCREASED 56
631 UPPER LIMB FRACTURE 56
632 WOUND INFECTION 56
633 ANGINA UNSTABLE 55
634 BLOOD CHLORIDE DECREASED 55
635 BLOOD URIC ACID INCREASED 55
636 BONE DENSITY DECREASED 55
637 FREQUENT BOWEL MOVEMENTS 55
638 HAEMODIALYSIS 55
639 INCREASED TENDENCY TO BRUISE 55
640 INJECTION SITE REACTION 55
641 INTESTINAL HAEMORRHAGE 55
642 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 55
643 LOCAL SWELLING 55
644 MALNUTRITION 55
645 MYOPATHY 55
646 PRODUCT PRESCRIBING ISSUE 55
647 SINUS TACHYCARDIA 55
648 THERAPEUTIC AGENT TOXICITY 55
649 CARDIAC FAILURE CHRONIC 54
650 DEVICE RELATED INFECTION 54
651 EUGLYCAEMIC DIABETIC KETOACIDOSIS 54
652 FIBROMYALGIA 54
653 NEUTROPHIL COUNT DECREASED 54
654 THERAPEUTIC RESPONSE SHORTENED 54
655 ANKLE FRACTURE 53
656 CONJUNCTIVITIS 53
657 DIPLOPIA 53
658 FRUSTRATION TOLERANCE DECREASED 53
659 HYPOCHLORAEMIA 53
660 NODULE 53
661 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 53
662 RENAL CYST 53
663 ALTERED STATE OF CONSCIOUSNESS 52
664 ANAPHYLACTIC SHOCK 52
665 BUNDLE BRANCH BLOCK LEFT 52
666 EMOTIONAL DISORDER 52
667 GLUCOSE TOLERANCE IMPAIRED 52
668 MULTIPLE SCLEROSIS 52
669 PLASMA CELL MYELOMA 52
670 PRODUCT STORAGE ERROR 52
671 SUBDURAL HAEMATOMA 52
672 ABDOMINAL PAIN LOWER 51
673 ABNORMAL DREAMS 51
674 BACK DISORDER 51
675 HEPATIC FAILURE 51
676 ISCHAEMIC CARDIOMYOPATHY 51
677 LEFT VENTRICULAR DYSFUNCTION 51
678 NEUROLEPTIC MALIGNANT SYNDROME 51
679 PERIPHERAL VASCULAR DISORDER 51
680 POTENTIATING DRUG INTERACTION 51
681 SECRETION DISCHARGE 51
682 SUPRAVENTRICULAR EXTRASYSTOLES 51
683 ACCIDENTAL OVERDOSE 50
684 BLOOD CALCIUM INCREASED 50
685 BRONCHOSPASM 50
686 BURSITIS 50
687 CEREBRAL INFARCTION 50
688 DRUG RESISTANCE 50
689 FACE OEDEMA 50
690 IMPAIRED QUALITY OF LIFE 50
691 MUSCLE TWITCHING 50
692 RENAL PAIN 50
693 SCAR 50
694 SKIN FISSURES 50
695 TROPONIN INCREASED 50
696 AGGRESSION 49
697 ASPIRATION 49
698 BRAIN FOG 49
699 CANDIDA INFECTION 49
700 GLOSSODYNIA 49
701 MOOD SWINGS 49
702 SKIN CANCER 49
703 SUPRAVENTRICULAR TACHYCARDIA 49
704 WEIGHT FLUCTUATION 49
705 ABASIA 48
706 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 48
707 DRUG EFFECT INCOMPLETE 48
708 FOETAL EXPOSURE DURING PREGNANCY 48
709 INCONTINENCE 48
710 INCREASED APPETITE 48
711 LUNG INFILTRATION 48
712 MOOD ALTERED 48
713 PHARYNGEAL SWELLING 48
714 SCOLIOSIS 48
715 SKIN IRRITATION 48
716 ABNORMAL BEHAVIOUR 47
717 AORTIC ARTERIOSCLEROSIS 47
718 BLOOD PRESSURE SYSTOLIC DECREASED 47
719 CAROTID ARTERY STENOSIS 47
720 CHANGE OF BOWEL HABIT 47
721 DIVERTICULUM 47
722 EMPHYSEMA 47
723 EPILEPSY 47
724 EYE INFECTION 47
725 HEPATIC ENCEPHALOPATHY 47
726 HEPATOMEGALY 47
727 JOINT RANGE OF MOTION DECREASED 47
728 MENINGITIS ASEPTIC 47
729 PNEUMONIA VIRAL 47
730 PROCEDURAL PAIN 47
731 PRODUCT DISPENSING ERROR 47
732 PRODUCT DOSE OMISSION IN ERROR 47
733 AORTIC STENOSIS 46
734 BLOOD CALCIUM DECREASED 46
735 CARDIOVASCULAR DISORDER 46
736 MACULAR DEGENERATION 46
737 PRODUCT ADMINISTRATION INTERRUPTED 46
738 PURPURA 46
739 ACUTE CORONARY SYNDROME 45
740 ATRIOVENTRICULAR BLOCK COMPLETE 45
741 BACTERAEMIA 45
742 DECREASED ACTIVITY 45
743 DERMATITIS ATOPIC 45
744 HOSPICE CARE 45
745 MENTAL IMPAIRMENT 45
746 MUSCLE ATROPHY 45
747 PHOTOSENSITIVITY REACTION 45
748 PNEUMOTHORAX 45
749 BODY HEIGHT DECREASED 44
750 GENERALISED TONIC-CLONIC SEIZURE 44
751 LEFT VENTRICULAR FAILURE 44
752 MICTURITION URGENCY 44
753 MUSCULOSKELETAL DISORDER 44
754 NERVOUS SYSTEM DISORDER 44
755 RESPIRATORY ARREST 44
756 RHINITIS 44
757 SENSITISATION 44
758 ACTIVITIES OF DAILY LIVING IMPAIRED 43
759 ANOREXIA 43
760 BLOOD GLUCOSE FLUCTUATION 43
761 HEMIPARESIS 43
762 INFUSION SITE HAEMORRHAGE 43
763 MUCOSAL DRYNESS 43
764 PLATELET COUNT INCREASED 43
765 ROTATOR CUFF SYNDROME 43
766 SCAB 43
767 SKIN HAEMORRHAGE 43
768 CHOKING 42
769 CHRONIC SINUSITIS 42
770 EAR DISCOMFORT 42
771 ERYTHEMA MULTIFORME 42
772 GYNAECOMASTIA 42
773 IRON DEFICIENCY 42
774 LYMPHOEDEMA 42
775 NERVE COMPRESSION 42
776 ORAL HERPES 42
777 POLYDIPSIA 42
778 PRODUCT ADMINISTRATION ERROR 42
779 VITAMIN D DEFICIENCY 42
780 APHONIA 41
781 CRYING 41
782 DEVICE OCCLUSION 41
783 DRY THROAT 41
784 EXPIRED PRODUCT ADMINISTERED 41
785 IRRITABLE BOWEL SYNDROME 41
786 LEFT ATRIAL DILATATION 41
787 LIVER INJURY 41
788 LOSS OF EMPLOYMENT 41
789 MIDDLE INSOMNIA 41
790 PAIN OF SKIN 41
791 RECTAL POLYP 41
792 RETINAL DETACHMENT 41
793 SLUGGISHNESS 41
794 TOOTH INFECTION 41
795 ATRIOVENTRICULAR BLOCK FIRST DEGREE 40
796 BACTERIAL INFECTION 40
797 DRUG ADMINISTRATION ERROR 40
798 EXTRA DOSE ADMINISTERED 40
799 EXTRAPYRAMIDAL DISORDER 40
800 GRIP STRENGTH DECREASED 40
801 HIP ARTHROPLASTY 40
802 LOCALISED OEDEMA 40
803 SUBARACHNOID HAEMORRHAGE 40
804 TOOTH DISORDER 40
805 VITAMIN D DECREASED 40
806 APPETITE DISORDER 39
807 BENIGN PROSTATIC HYPERPLASIA 39
808 BLOOD LACTIC ACID INCREASED 39
809 BODY TEMPERATURE INCREASED 39
810 BRONCHIECTASIS 39
811 CREPITATIONS 39
812 DEVICE DIFFICULT TO USE 39
813 DEVICE INFUSION ISSUE 39
814 DIABETIC NEUROPATHY 39
815 DRUG DEPENDENCE 39
816 FRACTURE 39
817 HAEMOLYTIC ANAEMIA 39
818 HUNGER 39
819 INTERVERTEBRAL DISC DEGENERATION 39
820 ORAL CANDIDIASIS 39
821 PARANASAL SINUS DISCOMFORT 39
822 PEMPHIGOID 39
823 PRESCRIBED UNDERDOSE 39
824 PRODUCT ODOUR ABNORMAL 39
825 SPINAL DISORDER 39
826 WRIST FRACTURE 39
827 WRONG TECHNIQUE IN DRUG USAGE PROCESS 39
828 ACUTE HEPATIC FAILURE 38
829 AORTIC VALVE INCOMPETENCE 38
830 COMPLICATION ASSOCIATED WITH DEVICE 38
831 COORDINATION ABNORMAL 38
832 ECCHYMOSIS 38
833 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 38
834 SARS-COV-2 TEST POSITIVE 38
835 SKIN INFECTION 38
836 SMALL INTESTINAL OBSTRUCTION 38
837 STRESS CARDIOMYOPATHY 38
838 TARDIVE DYSKINESIA 38
839 TRIGGER FINGER 38
840 COLITIS ISCHAEMIC 37
841 INCORRECT PRODUCT ADMINISTRATION DURATION 37
842 LIPASE INCREASED 37
843 LOW DENSITY LIPOPROTEIN INCREASED 37
844 ORAL DISORDER 37
845 PARKINSONISM 37
846 PHOTOPHOBIA 37
847 SPINAL OPERATION 37
848 UPPER-AIRWAY COUGH SYNDROME 37
849 AGRANULOCYTOSIS 36
850 ANGER 36
851 BACK INJURY 36
852 DRUG LEVEL ABOVE THERAPEUTIC 36
853 FAECES SOFT 36
854 GROIN PAIN 36
855 HEPATOCELLULAR INJURY 36
856 PARAESTHESIA ORAL 36
857 POLYNEUROPATHY 36
858 VAGINAL HAEMORRHAGE 36
859 ACUTE PULMONARY OEDEMA 35
860 APATHY 35
861 BLOOD ALBUMIN DECREASED 35
862 BLOOD TEST ABNORMAL 35
863 CATHETERISATION CARDIAC 35
864 CONJOINED TWINS 35
865 DERMATITIS 35
866 DEVICE BREAKAGE 35
867 DISABILITY 35
868 EYE HAEMORRHAGE 35
869 GASTRITIS EROSIVE 35
870 GOITRE 35
871 HAIR COLOUR CHANGES 35
872 INGUINAL HERNIA 35
873 INSURANCE ISSUE 35
874 LIBIDO DECREASED 35
875 MALIGNANT MELANOMA 35
876 NEPHROTIC SYNDROME 35
877 OBSTRUCTIVE SLEEP APNOEA SYNDROME 35
878 PERIORBITAL OEDEMA 35
879 PETECHIAE 35
880 PROSTATOMEGALY 35
881 RESPIRATORY RATE INCREASED 35
882 SKIN ATROPHY 35
883 SPRUE-LIKE ENTEROPATHY 35
884 TENDERNESS 35
885 WRONG PRODUCT ADMINISTERED 35
886 BEDRIDDEN 34
887 CAROTID ARTERIOSCLEROSIS 34
888 CYST 34
889 DERMATITIS EXFOLIATIVE 34
890 DYSPNOEA AT REST 34
891 ELECTROCARDIOGRAM ABNORMAL 34
892 FEELING JITTERY 34
893 GINGIVITIS 34
894 HYPERKERATOSIS 34
895 JOINT DISLOCATION 34
896 PHARMACEUTICAL PRODUCT COMPLAINT 34
897 PHARYNGEAL OEDEMA 34
898 POST PROCEDURAL INFECTION 34
899 PROTHROMBIN TIME PROLONGED 34
900 RED CELL DISTRIBUTION WIDTH INCREASED 34
901 SCRATCH 34
902 SKIN REACTION 34
903 SNORING 34
904 SUDDEN DEATH 34
905 THINKING ABNORMAL 34
906 CARDIAC PACEMAKER INSERTION 33
907 CLOSTRIDIUM DIFFICILE COLITIS 33
908 DRUG DOSE OMISSION BY DEVICE 33
909 GASTRIC HAEMORRHAGE 33
910 HAEMATOCRIT INCREASED 33
911 HAEMODYNAMIC INSTABILITY 33
912 HIGH DENSITY LIPOPROTEIN DECREASED 33
913 HYPERNATRAEMIA 33
914 HYPERURICAEMIA 33
915 HYPOALBUMINAEMIA 33
916 NEUTROPHILIA 33
917 ORAL DISCOMFORT 33
918 RETROPERITONEAL HAEMATOMA 33
919 SENSORY LOSS 33
920 TOOTH FRACTURE 33
921 VARICOSE VEIN 33
922 VENTRICULAR HYPOKINESIA 33
923 ADRENAL INSUFFICIENCY 32
924 BLINDNESS UNILATERAL 32
925 BLOOD LACTATE DEHYDROGENASE INCREASED 32
926 BREAST PAIN 32
927 DEVICE USE ERROR 32
928 DIVERTICULUM INTESTINAL 32
929 DRUG TOXICITY 32
930 GANGRENE 32
931 HAEMOGLOBIN ABNORMAL 32
932 HYPOAESTHESIA ORAL 32
933 IMPAIRED WORK ABILITY 32
934 METASTASES TO BONE 32
935 MULTIPLE FRACTURES 32
936 MYASTHENIA GRAVIS 32
937 PARKINSON^S DISEASE 32
938 PRODUCT TASTE ABNORMAL 32
939 PRODUCT USE COMPLAINT 32
940 PYELONEPHRITIS 32
941 BLOOD CREATINE INCREASED 31
942 BOWEL MOVEMENT IRREGULARITY 31
943 CHRONIC GASTRITIS 31
944 COLON CANCER 31
945 CORONARY ARTERY STENOSIS 31
946 DECUBITUS ULCER 31
947 EAR DISORDER 31
948 HAEMORRHAGIC STROKE 31
949 HICCUPS 31
950 HYPOVENTILATION 31
951 JOINT EFFUSION 31
952 LYMPHOCYTE COUNT DECREASED 31
953 METASTASES TO LIVER 31
954 NO THERAPEUTIC RESPONSE 31
955 OCULAR DISCOMFORT 31
956 OESOPHAGEAL CANDIDIASIS 31
957 PSYCHOMOTOR HYPERACTIVITY 31
958 PULSE ABSENT 31
959 QUALITY OF LIFE DECREASED 31
960 SALIVARY HYPERSECRETION 31
961 TOOTH ABSCESS 31
962 TOXIC SKIN ERUPTION 31
963 VASCULAR DEVICE INFECTION 31
964 ANAL INCONTINENCE 30
965 BLOOD ELECTROLYTES ABNORMAL 30
966 BLOOD POTASSIUM ABNORMAL 30
967 CONGESTIVE CARDIOMYOPATHY 30
968 DRUG DISPENSING ERROR 30
969 EXPOSURE VIA SKIN CONTACT 30
970 FLANK PAIN 30
971 HYPERLACTACIDAEMIA 30
972 HYPONATRAEMIC SEIZURE 30
973 LUNG INFECTION 30
974 MUSCLE STRAIN 30
975 NAIL DISORDER 30
976 NEPHROPATHY TOXIC 30
977 NEUTROPHIL COUNT INCREASED 30
978 OSTEONECROSIS OF JAW 30
979 PERITONITIS 30
980 WALKING AID USER 30
981 ABNORMAL LOSS OF WEIGHT 29
982 ATAXIA 29
983 ATRIOVENTRICULAR BLOCK SECOND DEGREE 29
984 BLOOD LOSS ANAEMIA 29
985 DRUG PRESCRIBING ERROR 29
986 EXERCISE TOLERANCE DECREASED 29
987 HAEMORRHOIDAL HAEMORRHAGE 29
988 HEREDITARY ANGIOEDEMA 29
989 KETOACIDOSIS 29
990 METABOLIC ENCEPHALOPATHY 29
991 MUSCLE SPASTICITY 29
992 OXYGEN CONSUMPTION INCREASED 29
993 PRE-EXISTING CONDITION IMPROVED 29
994 PRESCRIBED OVERDOSE 29
995 PRODUCT AVAILABILITY ISSUE 29
996 RENAL MASS 29
997 RESPIRATORY SYNCYTIAL VIRUS INFECTION 29
998 SENSORY DISTURBANCE 29
999 SUSPECTED SUICIDE 29